BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAFV600E-Mutated Lung Adenocarcinoma

Pierre de Priester; Lodovica Zullo; Damien Vasseur; Beatriz Alonso De Castro; Arianna Marinello; Luc Friboulet; David Planchard; Benjamin Besse; Mihaela Aldea

doi:10.1200/PO-24-00694

BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAF^V600E-Mutated Lung Adenocarcinoma

Pierre de Priester, Lodovica Zullo, Damien Vasseur, Beatriz Alonso De Castro, Arianna Marinello, Luc Friboulet, David Planchard, Benjamin Besse, Mihaela Aldea

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

langue originale	Anglais
Numéro d'article	e2400694
journal	JCO Precision Oncology
Volume	9
Les DOIs	https://doi.org/10.1200/PO-24-00694
état	Publié - 1 avr. 2025

Accès au document

10.1200/PO-24-00694

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

de Priester, P., Zullo, L., Vasseur, D., De Castro, B. A., Marinello, A., Friboulet, L., Planchard, D., Besse, B., & Aldea, M. (2025). BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAF^V600E-Mutated Lung Adenocarcinoma. JCO Precision Oncology, 9, Article e2400694. https://doi.org/10.1200/PO-24-00694

@article{d5a8d6109ea343d99a92108c3754fbb6,

title = "BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAFV600E-Mutated Lung Adenocarcinoma",

author = "{de Priester}, Pierre and Lodovica Zullo and Damien Vasseur and {De Castro}, {Beatriz Alonso} and Arianna Marinello and Luc Friboulet and David Planchard and Benjamin Besse and Mihaela Aldea",

year = "2025",

month = apr,

day = "1",

doi = "10.1200/PO-24-00694",

language = "English",

volume = "9",

journal = "JCO Precision Oncology",

issn = "2473-4284",

}

de Priester, P, Zullo, L, Vasseur, D, De Castro, BA, Marinello, A, Friboulet, L, Planchard, D, Besse, B & Aldea, M 2025, 'BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAF^V600E-Mutated Lung Adenocarcinoma', JCO Precision Oncology, VOL. 9, e2400694. https://doi.org/10.1200/PO-24-00694

BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAF^V600E-Mutated Lung Adenocarcinoma. / de Priester, Pierre; Zullo, Lodovica; Vasseur, Damien et al.
Dans: JCO Precision Oncology, Vol 9, e2400694, 01.04.2025.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAFV600E-Mutated Lung Adenocarcinoma

AU - de Priester, Pierre

AU - Zullo, Lodovica

AU - Vasseur, Damien

AU - De Castro, Beatriz Alonso

AU - Marinello, Arianna

AU - Friboulet, Luc

AU - Planchard, David

AU - Besse, Benjamin

AU - Aldea, Mihaela

PY - 2025/4/1

Y1 - 2025/4/1

UR - http://www.scopus.com/inward/record.url?scp=105003482505&partnerID=8YFLogxK

U2 - 10.1200/PO-24-00694

DO - 10.1200/PO-24-00694

M3 - Article

AN - SCOPUS:105003482505

SN - 2473-4284

VL - 9

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2400694

ER -